INEGY 10 MG20 MG TABLETS

Ország: Izrael

Nyelv: angol

Forrás: Ministry of Health

Aktív összetevők:

EZETIMIBE; SIMVASTATIN

Beszerezhető a:

MERCK SHARP & DOHME ISRAEL LTD

ATC-kód:

C10AA01

Gyógyszerészeti forma:

TABLETS

Összetétel:

SIMVASTATIN 20 MG; EZETIMIBE 10 MG

Az alkalmazás módja:

PER OS

Recept típusa:

Required

Gyártó:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terápiás csoport:

SIMVASTATIN

Terápiás terület:

SIMVASTATIN

Terápiás javallatok:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Engedély dátuma:

2012-04-30